Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis,

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the opening for patient screening and enrollment of …, Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the opening for patient screening and enrollment of …, Read More

Scroll to Top